Ling Qi

University of Virginia

NIH Rank #2741
  • R01 Holder
  • Translational
  • Early Career

NIH Funding · FY2024

Total Funding
$2.9M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#2,741
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.9M across 5 grants · National rank #2741.

Top grants by award amount

Ling Qi's NIH grant portfolio, ranked by award amount.

  • 1R01AG089640-01R01
    ERAD-STING Crosstalk in Microglia: Unraveling the Pathogenesis of Alzheimer's Disease
    $831.9K
    award amount
  • 7R01DK120330-06R01
    Novel role of hepatic SEL1L-HRD1 ERAD in bile acid metabolism
    $696.1K
    award amount
  • 5R01DK111174-09R01
    Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion
    $611.5K
    award amount
  • 7R01DK132786-02R01
    Mechanisms of ER-Protein Quality Control in Podocytes
    $397.1K
    award amount
  • 1R01DK137794-01R01
    A central role of SEL1L-HRD1 ERAD in LPL maturation in adipocytes
    $389.2K
    award amount

Affiliations

Institutions that have administered grants for Ling Qi.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Virginia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2741
  6. 2024
    Entered Top 25% Nationally
    Ranked #2741
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions